Failure of ε-Aminocaproic Acid in the Treatment of Scleroderma
Open Access
- 1 March 1966
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 25 (2) , 175-177
- https://doi.org/10.1136/ard.25.2.175
Abstract
[epsilon]-Aminocaproic acid was not found to be of any definite benefit in 7 patients with scleroderma and in one patient with dermatomyositis.This publication has 4 references indexed in Scilit:
- AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSISThe Lancet Healthy Longevity, 1965
- Antifibrinolytic Drug in Treatment of Progressive Systemic SclerosisPublished by American Medical Association (AMA) ,1963
- Morning Stiffness in Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1960
- ON THE CLINICAL RECOGNITION OF STRUCTURAL DISEASE OF THE PERIPHERAL VESSELSBMJ, 1933